Shrier Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$250K Buy
4,003
+7
+0.2% +$442 0.08% 120
2026
Q2
$230K Buy
3,996
+146
+4% +$8.38K 0.08% 127
2026
Q1
$233K Sell
3,850
-53
-1% -$3.09K 0.09% 123
2025
Q4
$211K Buy
+3,903
New +$188K 0.08% 120

Other funds holding BMY

Shrier Wealth Management's BMY Position: Q3 2026 in Review

Shrier Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.18% in Q3 2026, buying an estimated $442 and bringing the position to 4,003 shares worth $250K. The position accounts for 0.08% of the portfolio, ranked #120.

Shrier Wealth Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Shrier Wealth Management held 4,003 shares of Bristol-Myers Squibb worth $250K as of Q3 2026.
  • Shrier Wealth Management bought 7 Bristol-Myers Squibb shares in Q3 2026, an estimated $442.
  • Bristol-Myers Squibb made up 0.08% of Shrier Wealth Management's portfolio in Q3 2026, its #120 holding.
  • Shrier Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
  • 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Shrier Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.